The role of nitric oxide (No) in osteoar thritis (oA) initiation in rats. relationship between nitric oxide and cytokine releases in osteoarthritis.
Introduction
osteoarthritis (oA) is the most common form of arthritis, affecting approximately 15% of the human population. 1 Due to its predilec tion for lower extremity joints such as the knee and hip, oA is the leading cause of lower extremity disability amongst older adults with an estimated lifetime risk for knee oA being approximately 40% in men and 47% in women. 2 oA is characterised by chronic degeneration of joint structures in 
Methods
Rat oA was induced by performing meniscectomy surgery while cartilage samples were collected 0, 7, and 14 days after surgery. cartilage cytokine levels were determined by using enzyme-linked immunosorbent assay, while other proteins were assessed by using Western blot
Results
In the time course of the study, nitric oxide was increased seven and 14 days after oA induction. pro-inflammatory cytokines including tumour necrosis factor (TnF)-α, interleukin (IL)-1β, and IL-6 were decreased. L-nG-nitroarginine methyl ester (L-nAMe, a non-specific nitric oxide synthase inhibitor) significantly decreased cartilage nitric oxide and blocked immune suppression. Further, L-nAMe decreased Matrix metalloproteinase (MMps) and increased tissue inhibitor of metalloproteinase (TIMp) expression in meniscectomised rats.
the body including the synovial membrane, cartilage, and bone tissues. 3 The classic characteristic of this disease is the degrada tion of cartilage, a hallmark of oA, in the joint space lead ing to swollen and 'creaky' joints. Although trauma is perhaps the first event in oA development, the host inflammatory response plays an important role in the pathogenesis of oA, and inflammation is believed to be the major factor in symptomatic oA. 4, 5 However, the mechanism of cartilage degradation remains unclear.
matrix metalloproteinase (mmp) has been reported to play a crucial role in regulating cartilage breakdown. 6 The concentration of mmps in synovial fluid and cartilage in osteoarthritis patients is elevated, which is positively associated with the severity of osteoarthritis. 79 further, tissue inhibitors of metalloproteinases (Timps) act in the tissue environment to neutralise used proteinases, thereby preventing excessive and unwanted degradation away from the sites of metalloproteinase production.
Nitric oxide (No) is a predominant mediator in pro gression of oA and chondrocyte apoptosis. 10, 11 A high degree of No in the serum and cartilage of patients with arthritis has been shown in relation to normal cases. 12, 13 increased No produced by inducible No synthase (iNoS) is an important catabolic element in the activation of tumour necrosis factor (TNf)α and interleukin (il)1β. 14 immunohistochemical analyses have confirmed the exist ence of iNoS in oA synoviocytes and chondrocytes. 15, 16 previous studies indicated that increased concentration of nitrite (a No metabolite) in serum and synovial fluid samples of patients with rheumatoid arthritis and oA and have therefore suggested a role for No as an inflamma tory mediator in rheumatic diseases. 15, 16 However, the exact mechanism in which No regulates the immune sys tem in oA chondrocytes remains unclear. The aim of the present study was to investigate the role of cartilage No in innate immune regulation and the initiation of oA in rats.
Materials and Methods
Animals. A total of 45 male Spf Sprague Dawley rats weighing 200 g to 300 g were obtained from laboratory Animal Center, National Cheng Kung University, Tainan, Taiwan. They were individually housed in a room with a 12hour dark/light cycle and central air conditioning (25°C, 70% humidity), were allowed free access to tap water, and fed a standard rodent diet from richmond Standard pmi feeds, inc (St louis, missouri), with or without a sesame oil supplement. The animal care and experimental protocols were followed in accordance with nationally approved guidelines. experimental designs. Experiment i was a time course study of meniscectomyinduced cartilage No and pro inflammatory cytokine production in rats. rats were divided into two groups of fifteen. group i (Sham group), rats received the sham operation only; and group ii (oA group) rats received a meniscectomy operation only. Cartilage nitrite (a marker for No production) and pro inflammatory cytokine including TNfα, il1β, and il6 were assessed 0, 7, and 14 days after the sham or menis cectomy operation.
Experiment ii considered the role of No in cartilage proinflammatory cytokine, mmps, and Timp levels. rats were divided into three groups of five. group i (sham group), rats received sham operation only; group ii (oA group), rats received meniscectomy operation only; and group iii (oAl group), rats received meniscectomy oper ation and lNgNitroarginine methyl ester (l NAmE, a nonspecific No synthase inhibitor) (20 mg/kg/d for 14 days, orally). Cartilage sample were collected 14 days after meniscectomy from groups i, ii, and iii, respectively. oA induction meniscectomy surgery was performed under 3.5% isofluorane inhalational anesthetics.
All rats received cephalexin (Ceporex oral drops) (0.03 ml/100 g body weight) one hour pre and 12, 24, and 36 hours postoperatively. A small incision was made longitu dinally down the medial side of the knee and a cauteriser was used to work through both the connective tissue and muscle layers until the medial collateral ligament, anchor ing the medial meniscus to the tibial plateau, was identi fied. The ligament was grasped at the tibial end and cut until fully transected. The ligament was then transected again at the femoral end to remove the portion overlying the meniscus, which was freed from the fine connective tissue, allowing a full thickness medial meniscal transec tion. Sham animals underwent the same surgical proce dure with the omission of medial meniscal transection. 3 Protein concentration in cartilage. rat articular cartilage was collected after the rats were killed. We homogenised collected cartilage samples in icecold milliQ (mQ) water (1:10 w/v) with a tissue homogeniser. After centrifuga tion at 3000 g for ten minutes, supernatant was collected for protein assay. The protein concentration in tissue homogenate was determined by using protein assay dye (Biorad laboratories, Hercules, California) according to the commercial protocol. NO concentration in cartilage. We homogenised col lected cartilage samples in icecold mQ water (1:10 w/v) with a tissue homogeniser. After centrifugation at 3000 g for ten minutes, supernatant was collected. The amounts of nitrite in cartilage were measured following the griess reaction by incubating 100 µl of tissue homogenate with 100 µl of griess solution at room temperature for 20 min utes. The absorbance was measured at 550 nm by a spec trophotometer. 17 Nitrite concentration was calculated by comparison with a standard solution of known sodium nitrite concentrations. TNF-α, IL-1β, and IL-6 levels in cartilage. To examine the role of No in innate immunosuppression, cytokines (the commonly used biomarker of immune response) 18 including TNfα, il1β, and il6 in cartilage were deter mined. TNfα, il1β, and il6 levels were quantitatively measured by using an EliSA kit (DuoSet; r&D Systems inc., minneapolis, minnesota). Briefly, the sample was incubated with biotinylated rabbit antibody for two hours, after which streptavidineconjugated horseradish peroxidase was added for 20 minutes. The peroxidase reaction was initiated by adding 3,3',5,5'tetramethyl benzidine/H2o2 (r&D Systems) for 30 minutes, and then stopped by adding 0.5 m H2So4. The absorbance was measured at 450 nm. Western blotting. A 50microgram protein was loaded on SDS-pAgE, and then transferred to nitrocellulose sheets (NEN life Science products, inc., Boston, massachusetts). After blocking, the blots were incubated with mmp2, mmp9, Timp2, or βactin antibody (Abcam, Cambridge, United Kingdom) (dilution 1:1000) in 5% nonfat skimmed milk (using βactin as a loading control). After the blots were washed, they were incubated with sec ondary antibodies conjugated with alkaline phosphatase (dilution 1:3000) (Jackson immunoresearch laboratories inc., philadelphia, pennsylvania). immunoblots were developed using bromochloroindolyl phosphate/ nitroblue tetrazolium solution (Kirkegaard and perry laboratories inc., Baltimore, maryland). Statistical analysis. Data were expressed as mean and standard deviation (sd). oneway analysis of variance (ANovA) followed by student's ttest analysis was used to make pairwise comparisons between the groups. Statistical significance was set at p < 0.05.
Results
The time course of cartilage NO production and immune response in meniscectomy-induced OA. To examine the roles of No and the immune response in the initiation of oA, cartilage nitrite and cytokines were assessed.
Cartilage nitric levels in oA groups were significantly increased compared with that in the sham groups at day 14 after meniscectomy surgery ( fig. 2) . However, car tilage TNfα ( fig. 1a), il1β (fig. 1b), and il6 (fig. 1c ) levels in the oA group were significantly lower compared with that of the sham group at postoperative days 7 and 14. Time course study of meniscectomyinduced cartilage proinflammatory cytokine production in rats. rats were divided into two groups of five. group i (Sham group), rats received the sham operation only; and group ii (oA group) rats received the meniscectomy operation only. Cartilage pro inflammatory cytokines including TNfα (Α), il1β (Β), and il6 (C) were assessed at 0, 7, and 14 days after sham or meniscectomy operation. Data are expressed as means and standard deviation. *p < 0.05 compared with Sham group (group i). addition, although the levels of TNfα ( fig. 4a), il1β (fig.  4b), and il6 (fig. 4c) were significantly decreased in both oA groups, lNAmE treatment maintained all measured cytokine levels in oAl groups (fig. 4) .
Role of NO in regulating cartilage breakdown in menis-
cectomy induced OA. To examine the role of No in regu lating cartilage breakdown, we assessed the active form mmp2 and mmp9, as well as Timp2 expression in carti lage. Both cartilage mmp2 and mmp9 expression were decreased in oA group compared with the sham group. However, mmp2 and mmp9 was significantly higher in the oAl group compared with that in the oA group ( fig. 5) . furthermore, lNAmE significantly reversed the increase of cartilage Timp2 expression. The Timp2 level in the oAl group showed no difference compared with that in the sham groups ( fig. 6 ).
Discussion
in the present study, we have illustrated the role of No in the initiation stage of cartilage damage in rats. inhibiting cartilage No synthesis blocked immune suppression, as well as decreased mmps and increased Timp expression in meniscectomised rats. We suggest that No plays a pro tective role in the very early stage of cartilage breakdown and subsequent development of oA.
Accumulation of No may be associated with immune suppression in rat cartilage after meniscectomy. Although No has been regarded as a proinflammatory mediator, its role in regulating the immune response is still para doxical. 19 Some studies have indicated that No enhances the immune and inflammatory responses; 20, 21 however, other studies have shown that No suppresses immune response and inflammation. 22, 23 in the present study, more No accumulation and less immune response was found in cartilage in the early stage of the experimental rat oA model. furthermore, inhibiting NoS activity by lNAmE blocked the immune suppression. it is likely that the accumulation of No may be involved in the suppres sion of the innate immune response in the early stage of cartilage damage.
Noassociated innate immune suppression may play a beneficial role in maintaining cartilage integrity in the early stages of oA. Articular cartilage is considered to be 'immune privileged' 24 , meaning it is able to tolerate the introduction of antigens without eliciting an inflamma tory immune response, in that transplanted cartilage from unrelated donors does not elicit immune rejection responses. 25, 26 previous studies have indicated that pros taglandin (pg) E2 mediates the immune suppression in cartilage. 27, 28 inhibiting pgE2 by using nonsteroidal anti inflammatory drugs (NSAiDs) accelerated cartilage break down in experimental and clinical studies. 29, 30 moreover, one of the recent clinical trials of potent antiinflamma tory therapies, including the use of systemic and intra articular biological agents to inhibit TNfα and il1β The effect of lNAmE on cartilage nitric oxide production in rats. rats were divided into three groups of five. group i (sham group), rats received the sham operation only; group ii (oA, group), rats received the meniscectomy operation only; and group iii (oAl group), rats received the meniscectomy operation and lNAmE (20 mg/kg/d for 14 days, orally). Cartilage nitrite levels were determined 14 days after meniscectomy from each group, respectively. Data are expressed as means and standard deviation *p < 0.05 compared with sham group (group i). #p < 0.05 compared with oA group (group ii). The role on nitric oxide on cartilage proinflammatory cytokine production in rats. rats were divided into three groups of five. group i (sham group), rats received the sham operation only; group ii (oA group), rats received the meniscectomy operation only; and group iii (oAl group), rats received the meniscec tomy operation and lNAmE (20 mg/kg/d for 14 days, orally). Cartilage proinflammatory cytokines including TNfα (Α), il1β (Β), and il6 (C) were assessed 14 days after meniscectomy from each group, respectively. Data are expressed as means and standard deviation. *p < 0.05 compared with Sham group (group i). #p < 0.05 compared with oA group (group ii).
proved disappointing. 31 Therefore, the maintaining of immune suppression may be beneficial in confronting cartilage contact stress during the initiation of oA. in the present study, lNAmE decreased the accumulation of No in cartilage and relieved the suppression of the innate immune response. Therefore, No may play a protective role against cartilage breakdown in initiating rat oA. Cartliage may be protected by No regulating the bal ance between mmp and Timp, both of which are involved in the pathogenesis of cartilage breakdown. 32, 33 A previous study indicated that No decreases mmp2 and increases Timp2 expression. 33 in the present study, increased accu mulation of No accompanied with decreased mmps and increased Timp2 expression were observed in cartilage after meniscectomy. inhibiting No production by lNAmE reversed the changes of mmps and Timp2 expression. This evidence proves our hypothesis that No plays a pro tective role against cartilage breakdown in the early stage of oA. However, further study is required to confirm this. in conclusion, Nodependent innate immunosuppres sion protects cartilage from damage in the early stage of oA initiation in rats. The role on nitric oxide on cartilage mmps levels in rats. rats were divided into three groups of five. group i (sham group), rats received the sham operation only; group ii (oA group), rats received the meniscectomy operation only; and group iii (oAl group), rats received the meniscectomy operation and lNAmE (20 mg/kg/d for 14 days, orally). Cartilage levels of mmp2 (A) and mmp9 (B) were assessed 14 days after meniscectomy from each group, respectively. Data are expressed as means and standard deviation. *p < 0.05 compared with Sham group (group i). #p < 0.05 compared with oA group (group ii). The role on nitric oxide on cartilage Timp2 expression in rats. rats were divided into three groups of five. group i (sham group), rats received the sham operation only; group ii (oA group), rats received the meniscectomy operation only; and group iii (oAl group), rats received the meniscectomy operation and lNAmE (20 mg/kg/d for 14 days, orally). The cartilage level of Timp2 expression was assessed 14 days after meniscectomy from each group, respectively. Data are expressed as means and standard deviation. *p < 0.05 compared with the sham group (group i). #p < 0.05 compared with oA group (group ii).
